Last10K.com

Item 9 Labs Corp. (INLB) SEC Filing 10-K Annual Report for the fiscal year ending Friday, September 30, 2022

Item 9 Labs Corp.

CIK: 1500123 Ticker: INLB
Cover - USD ($)
12 Months Ended
Sep. 30, 2022
Jan. 13, 2023
Mar. 31, 2022
Cover [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Annual Reporttrue  
Document Transition Reportfalse  
Document Period End DateSep. 30, 2022  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2022  
Current Fiscal Year End Date--09-30  
Entity File Number000-54730  
Entity Registrant NameITEM 9 LABS CORP.  
Entity Central Index Key0001500123  
Entity Tax Identification Number96-0665018  
Entity Incorporation, State or Country CodeDE  
Entity Address, Address Line One2727 North 3rd Street  
Entity Address, Address Line TwoSuite 201  
Entity Address, City or TownPhoenix  
Entity Address, State or ProvinceAZ  
Entity Address, Postal Zip Code85004  
City Area Code833  
Local Phone Number867-6337  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 117,894,392
Entity Common Stock, Shares Outstanding 100,002,264 
ICFR Auditor Attestation Flagfalse  
Auditor NameBF Borgers CPA PC  
Auditor Firm ID5041  
Auditor LocationLakewood, CO  

View differences made from one year to another to evaluate Item 9 Labs Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Item 9 Labs Corp..

Continue

Assess how Item 9 Labs Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Item 9 Labs Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (Parenthetical)
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Operations
Allocation Of Estimated Purchase Price To Estimated Fair Values Of Assets Acquired And Liabilities Assumed (Details)
Allocation Of Purchase Price To Estimated Fair Values Of Assets Acquired (1) (Details)
Assets Held For Sale And Related Liabilities (Details)
Assumptions Used To Estimate Fair Value Of Stock Options (Details)
Assumptions Used To Estimate Fair Value Of Warrants (Details)
Carrying Values Of Assets And Liabilities Of Vie Consolidated By The Company (Details)
Components Of Net Deferred Taxes (Details)
Consideration Paid Or Accrued For Acquisition (1) (Details)
Consideration Paid Or Accrued For Acquisition (2) (Details)
Convertible Notes Payable (Details)
Effective Income Tax Rate Reconciliation (Details)
Federal And State Net Operating Loss Carryforwards Expiration (Details)
Future Amortization (Details)
Future Lease Payments (Details)
Future Minimum Payments Of Company's Convertible Debt Obligations (Details)
Future Minimum Payments Of Company's Notes Payable Obligations (Details)
Goodwill And Identifiable Intangible Assets, Including Licenses (Details)
Income Tax Provision (Details)
Inventory (Details)
Note 1 - Description Of Business And Summary Of Significant Accounting Policies
Note 1 - Description Of Business And Summary Of Significant Accounting Policies (Details Narrative)
Note 1 - Description Of Business And Summary Of Significant Accounting Policies (Policies)
Note 1 - Description Of Business And Summary Of Significant Accounting Policies (Tables)
Note 10 - Commitments And Contingencies
Note 10 - Commitments And Contingencies (Details Narrative)
Note 10 - Commitments And Contingencies (Tables)
Note 11 - Related Party Transactions
Note 11 - Related Party Transactions (Details Narrative)
Note 12 ??? Assets Held For Sale
Note 12 ??? Assets Held For Sale (Details Narrative)
Note 12 ??? Assets Held For Sale (Tables)
Note 13 - Stockholders' Equity
Note 13 - Stockholders' Equity (Details Narrative)
Note 13 - Stockholders' Equity (Tables)
Note 14 ??? Income Taxes
Note 14 ??? Income Taxes (Details Narrative)
Note 14 ??? Income Taxes (Tables)
Note 15 ??? Segment Information
Note 15 ??? Segment Information (Tables)
Note 16 - Subsequent Events
Note 2 - Going Concern
Note 3 ??? Inventory
Note 3 ??? Inventory (Tables)
Note 4 - Acquisitions
Note 4 - Acquisitions (Details Narrative)
Note 4 - Acquisitions (Tables)
Note 5 ??? Variable Interest Entity
Note 5 ??? Variable Interest Entity (Tables)
Note 6 ??? Goodwill And Intangible Assets
Note 6 ??? Goodwill And Intangible Assets (Details Narrative)
Note 6 ??? Goodwill And Intangible Assets (Tables)
Note 7 ??? Property And Equipment, Net
Note 7 ??? Property And Equipment, Net (Details Narrative)
Note 7 ??? Property And Equipment, Net (Tables)
Note 8 - Debt
Note 8 - Debt (Tables)
Note 9 - Concentrations
Notes Payable (Details)
Ocg Acquisition - Fair Value Of Consideration Paid (Details)
Operations (After Intercompany Eliminations) Of Vie Consolidated By The Company (Details)
Property And Equipment (Details)
Revenue Disaggregated By Source (Details)
Securities Outstanding (Details)
Segment Information (Details)
Stock Option Activity (Details)
Summary Of Interest Expense (Details)
Unaudited Pro Forma Information (Details)
Warrant Activity (Details)

Material Contracts, Statements, Certifications & more

Item 9 Labs Corp. provided additional information to their SEC Filing as exhibits

Ticker: INLB
CIK: 1500123
Form Type: 10-K Annual Report
Accession Number: 0001554795-23-000012
Submitted to the SEC: Fri Jan 13 2023 4:06:29 PM EST
Accepted by the SEC: Fri Jan 13 2023
Period: Friday, September 30, 2022
Industry: Dental Equipment And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/inlb/0001554795-23-000012.htm